miR-200c/Bmi1 axis and epithelial–mesenchymal transition contribute to acquired resistance to BRAF inhibitor treatment

Resistance to BRAF inhibitors (BRAFi) is one of the major challenges for targeted therapies for BRAF-mutant melanomas. However, little is known about the role of microRNAs in conferring BRAFi resistance. Herein, we demonstrate that miR-200c expression is significantly reduced whereas miR-200c target...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pigment Cell Melanoma Res
Main Authors: Liu, Shujing, Tetzlaff, Michael T., Wang, Tao, Yang, Ruifeng, Xie, Lin, Zhang, Gao, Krepler, Clemens, Xiao, Min, Beqiri, Marilda, Xu, Wei, Karakousis, Giorgos, Schuchter, Lynn, Amaravadi, Ravi K., Xu, Weiting, Wei, Zhi, Herlyn, Meenhard, Yao, Yuan, Zhang, Litao, Wang, Yingjie, Zhang, Lin, Xu, Xiaowei
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4597606/
https://ncbi.nlm.nih.gov/pubmed/25903073
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/pcmr.12379
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados